C

Carterra

87 employees

Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition technologies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
label-free
biotechnology
protein-protein
Information Services
epitope mapping
immunity monitoring
kinetic characterization
SPR
phage display
serology
antibody discovery
hybridoma
hybridoma screening
B Cell Cloning
neuroscience
vaccine research
covid19
infectious disease
Developer Platform
antibody development
B-Cell Enrichment
Medical
cancer
epitope binning
immunooncology

Date founded

2005

Funding rounds raised

Total raised

$8.1M

from 5 investors over 5 rounds

C

Carterra raised $8.1M on December 14, 2020

Investors: Ballast Point Ventures and Telegraph Hill Partners

C

Carterra raised $6M on January 14, 2020

Investors: Ballast Point Ventures and Telegraph Hill Partners

C

Carterra raised $200K on January 25, 2012

Investors: -

FAQ